… Treatments of lung disease after COVID-19 are being … of lung fibrosis after COVID-19. Future
research is needed to determine the long-term persistence of lung disease after COVID-19, …

… the post- COVID-19 lung complications. More long-term follow-up studies are warranted to
determine the exact prevalence and prognosis of various post-COVID-19 complications, and …

… 2, known as Coronavirus Disease 2019, abbreviated as COVID-19 had escalated across
the globe creating a major health crisis. This deadly virus belongs to a genus β-coronavirus [1], …

… or lung fibrosis. The published data regarding the influence of smoking on the course of
COVID-19 … Liu et al. noticed that tobacco smoking contributes to the progression of a COVID-19 …

… The reasons for hospital readmissions were progression of lung involvement due to COVID-19
pneumonia, respiratory failure, unspecified infectious diseases, cardiovascular diseases, …

… in treatment of the cytokine storm in COVID-19 patients. This manuscript provides an …
COVID-19 to advocate for and support studies of these technologies in the current coronavirus …

… LYT-100 is designed to be a potential treatment for IPF, interstitial lung diseases with fibrosis,
respiratory COVID complications and related consequences, as well as lymphatic Bessel …

… COVID-19 could cause injuries in the lungs, liver, kidney, heart, … complications of severe
COVID-19 infection; the majority of hospitalized COVID-19 patients suffer from severe lung …

… highlight the clinical complications related to COVID-19. Methods: … clinical complications
and pathogenesis of COVID-19. … the lungs are the most commonly involved sites of COVID-19 …

… , no effective treatments for lung complications of COVID‑19 are available for the most …
theranostics of COVID-19 pulmonary infection and associated lung complications and foster …